Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Angiogenesis
|
April 24, 2016
mTORC2 mediates CXCL12-induced angiogenesis
Mary E Ziegler, Michaela M S Hatch, Nan Wu, et al.
Plos One
|
January 26, 2019
IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages
Ellen O Weinberg, Beatriz Ferran, Yuko Tsukahara, et al.
Breast Cancer Research : BCR
|
May 13, 2016
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
Michael J Gray, Jian Gong, Michaela M S Hatch, et al.
Cancer Immunology Research
|
April 6, 2016
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma
Bruce D Freimark, Jian Gong, Dan Ye, et al.
Biomaterials
|
December 5, 2016
Recapitulating the human tumor microenvironment: Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth
Mónica Romero-López, Andrew L Trinh, Agua Sobrino, et al.
Nature Communications
|
October 27, 2020
Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
Nan W Hultgren, Jennifer S Fang, Mary E Ziegler, et al.
Biofabrication
|
December 21, 2023
A vascularized 3D model of the human pancreatic islet for<i>ex vivo</i>study of immune cell-islet interaction
R Hugh F Bender, Benjamen T O'Donnell, Bhupinder Shergill, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Angiogenesis
|
April 24, 2016
mTORC2 mediates CXCL12-induced angiogenesis
Mary E Ziegler, Michaela M S Hatch, Nan Wu, et al.
Plos One
|
January 26, 2019
IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages
Ellen O Weinberg, Beatriz Ferran, Yuko Tsukahara, et al.
Breast Cancer Research : BCR
|
May 13, 2016
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
Michael J Gray, Jian Gong, Michaela M S Hatch, et al.
Cancer Immunology Research
|
April 6, 2016
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma
Bruce D Freimark, Jian Gong, Dan Ye, et al.
Biomaterials
|
December 5, 2016
Recapitulating the human tumor microenvironment: Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth
Mónica Romero-López, Andrew L Trinh, Agua Sobrino, et al.
Nature Communications
|
October 27, 2020
Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
Nan W Hultgren, Jennifer S Fang, Mary E Ziegler, et al.
Biofabrication
|
December 21, 2023
A vascularized 3D model of the human pancreatic islet for<i>ex vivo</i>study of immune cell-islet interaction
R Hugh F Bender, Benjamen T O'Donnell, Bhupinder Shergill, et al.
Page
of 1